BGJ Stock Chart & Stats
€61.60
€0.40(0.79%)
At close: 4:00 PM EST
€61.60
€0.40(0.79%)
Day’s Range― - ―
52-Week Range€56.60 - €73.60
Previous CloseN/A
Volume50.00
Average Volume (3M)5.00
Market Cap
€885.99M
Enterprise Value€1.62K
Total Cash (Recent Filing)€684.84M
Total Debt (Recent Filing)€1.24B
Price to Earnings (P/E)11.3
Beta0.21
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.73
Shares Outstanding14,032,930
10 Day Avg. Volume12
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.52
Price to Sales (P/S)0.13
P/FCF Ratio14.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€79.00Price Target Upside28.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)10.52
Revenue Forecast (FY)€7.77B
Bulls Say, Bears Say
Bulls Say
Manageable Leverage And Stable EquitySavencia's debt-to-equity around ~0.74 indicates conservative leverage for a packaged foods operator. That balance-sheet posture supports resilience to cyclical input shocks, preserves borrowing capacity for capital needs, and reduces interest burden risk over the medium term.
Diversified Branded And Professional ChannelsA two‑route model—branded retail products plus specialty/ingredient sales to professional customers—spreads revenue across channels and contracts. This structural mix lessens exposure to a single end market, helping sustain volumes and pricing flexibility across business cycles.
Relatively Strong Gross MarginsConsistent gross margins near the mid‑30s provide a durable buffer against milk, energy, and packaging cost swings. That structural margin level supports operating resilience and gives management scope to invest in brands or absorb temporary cost inflation without immediate margin collapse.
Bears Say
Revenue Decline In 2025A falling top line in 2025 interrupts prior growth momentum and reduces operating leverage. If revenue weakness persists, the company will face harder choices on pricing, promotions, and investment, limiting its ability to restore scale economics and long‑term margin recovery.
Weak Cash Conversion And Falling FCFDeclining operating cash flow and FCF covering only ~19% of net income materially reduce financial flexibility. Lower cash conversion constrains debt paydown, capital expenditure funding, and dividend sustainability, making the firm more vulnerable to profit shocks or external financing stress.
Thin Net Margin And Compressed Operating MarginsNet margin near 1.1% leaves little room to absorb commodity or operating cost increases. Compressed EBIT/EBITDA margins signal limited operating leverage and restrict ability to fund growth or returns, increasing sensitivity to input cost volatility and price competition over time.
Savencia News
BGJ FAQ
What was Savencia SA’s price range in the past 12 months?
Savencia SA lowest stock price was €56.60 and its highest was €73.60 in the past 12 months.
What is Savencia SA’s market cap?
Savencia SA’s market cap is €885.99M.
When is Savencia SA’s upcoming earnings report date?
Savencia SA’s upcoming earnings report date is Sep 10, 2026 which is in 22 days.
How were Savencia SA’s earnings last quarter?
Savencia SA released its earnings results on Mar 05, 2026. The company reported €2.798 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Savencia SA overvalued?
According to Wall Street analysts Savencia SA’s price is currently Undervalued.
Does Savencia SA pay dividends?
Savencia SA does not currently pay dividends.
What is Savencia SA’s EPS estimate?
Savencia SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Savencia SA have?
Savencia SA has 14,032,930 shares outstanding.
What happened to Savencia SA’s price movement after its last earnings report?
Savencia SA reported an EPS of €2.798 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.339%.
Which hedge fund is a major shareholder of Savencia SA?
Currently, no hedge funds are holding shares in DE:BGJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Savencia SA
Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.
BGJ Stock 12 Month Forecast
Average Price Target
€79.00
▲(28.25% Upside)
Technical Analysis
Bonduelle
―
DANONE SA
―
Fleury Michon
―
Societe LDC Societe Anonyme
―
Saint Jean Groupe SA
―

